Press release
July 28, 2026
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
Ultragenyx Pharmaceutical Inc. (RARE)
NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at